Catalyst Health Ventures — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Veracyteveracyte.comin𝕏NASDAQ: VCYTSep 2014
Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Julie Brooks(Executive Officer)Samuel D. Colella(Director)Shelly D. Guyer(Executive Officer)Fred E. Cohen(Director)Brian G. Atwood(Director)Evan Jones(Director)
Co-investorsKleiner Perkins
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.